Long‐Term Drop‐Seizure Response Patterns to Cannabidiol According to Genetic Status in Lennox–Gastaut Syndrome
CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)
DOI: 10.1002/cns.71221 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 01.11.2026. Verfasst von Ji-Hoon Na und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Kore…. Hauptthemen laut MEDLINE: Lennox Gastaut Syndrome, Cannabidiol, Anticonvulsants, Seizures. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lennox–Gastaut syndrome (LGS) is a genetically heterogeneous developmental and epileptic encephalopathy in which variability in long‐term cannabidiol (CBD) response remains incompletely understood. We evaluated whether long‐term drop‐seizure response trajectories to CBD differ according to genetic status.
Methods
This single‐center retrospective longitudinal study analyzed systematically collected clinical follow‐up data from 61 patients with LGS treated with pharmaceutical‐grade CBD; 46 patients with ≥ 24 months of follow‐up were included. Patients were classified as pathogenic/likely pathogenic variant‐positive (PV+) or variant‐negative (PV–). Drop‐seizure reduction trajectories were assessed at 3‐month intervals over 24 months.
Results
Drop‐seizure reduction improved rapidly and was sustained over 24 months in both PV+ and PV– groups, with no significant differences between groups at the prespecified comparison time points. Longitudinal response trajectories showed substantial overlap, and sustained response was observed in 76.1% of patients.
Conclusion
Long‐term drop‐seizure response to CBD in LGS was sustained but not stratified by genetic status, supporting a syndrome‐level treatment approach irrespective of genetic findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Ji-Hoon Na
Zitieren
APA
Na, J. H., Cho, H. Y., Jeon, H., Lee, H., & Lee, Y. M. (2026). Long‐Term Drop‐Seizure Response Patterns to Cannabidiol According to Genetic Status in Lennox–Gastaut Syndrome. CNS Neuroscience & Therapeutics, 32(11). https://doi.org/10.1002/cns.71221
Vancouver
Na JH, Cho HY, Jeon H, Lee H, Lee YM. Long‐Term Drop‐Seizure Response Patterns to Cannabidiol According to Genetic Status in Lennox–Gastaut Syndrome. CNS Neuroscience & Therapeutics. 2026;32(11). doi:10.1002/cns.71221
BibTeX
@article{Na2026,
author = {Na, Ji-Hoon and Cho, Hee Yeon and Jeon, Hayoon and Lee, Hyunjoo and Lee, Young-Mock},
title = {Long‐Term Drop‐Seizure Response Patterns to Cannabidiol According to Genetic Status in Lennox–Gastaut Syndrome},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {11},
doi = {10.1002/cns.71221}
}
EUVIMED